The researchers will study brain samples from individuals with bipolar disorder, schizophrenia, and major depressive disorder.
The consortium aims to advance the use of genomics in the clinic, with a particular focus on diverse and underserved patient populations.
The grant will fund a collaboration investigating whether genomic signatures and other biomarkers can be used in clinical diagnosis and monitoring of kidney cancer.
At the ACMG annual conference in Phoenix last week, several labs and companies discussed their efforts in healthy genome sequencing.
The number of institutions offering clinical exome or genome tests to healthy individuals keeps increasing, but the practice remains controversial among medical experts.
The Alabama Genomic Health Initiative aims to recruit participants from every county in the state and provide genomic analysis and interpretation free of charge.
The funding will, in part, support efforts to expand the project's catalog of functional elements and understand their roles in different contexts.
In phase two of a program started last year, 30-year-old women and men in five Alabama counties will be able to get an NGS-based cancer screening test for free over the next year.
Researchers took two complementary approaches to assemble the Xenopus laevis genome — whole-genome and long-insert clone-based end sequencing.
HudsonAlpha researchers are expected to sequence 20,000 patient tumor and non-tumor samples for ORIEN's Avatar initiative by 2019.
The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.
Kaiser Health News reports that gene therapies could cost more than a million dollars.
Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.
In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.